Chiara Singh1, Mary De Vera1, Kristin L Campbell2. 1. Fraser Health Authority, Surrey, B.C. 2. Department of Physical Therapy, University of British Columbia, Vancouver B.C.
Abstract
PURPOSE: Significant arm morbidity is reported following surgery for breast cancer, yet physiotherapy is not commonly part of usual care. This study compared the effect on arm morbidity after surgery for breast cancer of a clinical care pathway including preoperative education, prospective monitoring, and early physiotherapy (experimental group) to that of preoperative education alone (comparison group). METHODS: A prospective quasi-experimental pretest-posttest, non-equivalent group design compared two clinical sites; Site A (n=41) received the experimental intervention, and Site B (n=31) received the comparison intervention. At baseline (preoperative) and 7 months postoperative, shoulder range of motion (ROM), upper-extremity (UE) strength, UE circumference, pain, UE function, and quality of life were assessed. RESULTS: The experimental group maintained shoulder flexion ROM at 7 months, whereas the comparison group saw a decrease (mean 1° [SD 9°] vs. -6° [SD 15°], p=0.03). A lower incidence of arm morbidity and better quality of life were observed in the experimental group, but these findings were not statistically significant. Baseline characteristics and surgical approaches differed between the two sites, which may have had an impact on the findings. CONCLUSION: Initial results are promising and support the feasibility of integrating a surveillance approach into follow-up care. This pilot study provides the foundation for a larger, more definitive trial.
RCT Entities:
PURPOSE: Significant arm morbidity is reported following surgery for breast cancer, yet physiotherapy is not commonly part of usual care. This study compared the effect on arm morbidity after surgery for breast cancer of a clinical care pathway including preoperative education, prospective monitoring, and early physiotherapy (experimental group) to that of preoperative education alone (comparison group). METHODS: A prospective quasi-experimental pretest-posttest, non-equivalent group design compared two clinical sites; Site A (n=41) received the experimental intervention, and Site B (n=31) received the comparison intervention. At baseline (preoperative) and 7 months postoperative, shoulder range of motion (ROM), upper-extremity (UE) strength, UE circumference, pain, UE function, and quality of life were assessed. RESULTS: The experimental group maintained shoulder flexion ROM at 7 months, whereas the comparison group saw a decrease (mean 1° [SD 9°] vs. -6° [SD 15°], p=0.03). A lower incidence of arm morbidity and better quality of life were observed in the experimental group, but these findings were not statistically significant. Baseline characteristics and surgical approaches differed between the two sites, which may have had an impact on the findings. CONCLUSION: Initial results are promising and support the feasibility of integrating a surveillance approach into follow-up care. This pilot study provides the foundation for a larger, more definitive trial.
Entities:
Keywords:
breast neoplasms; lymphedema; muscle strength; range of motion; upper extremity
Authors: Barbara A Springer; Ellen Levy; Charles McGarvey; Lucinda A Pfalzer; Nicole L Stout; Lynn H Gerber; Peter W Soballe; Jerome Danoff Journal: Breast Cancer Res Treat Date: 2010-02 Impact factor: 4.872
Authors: Nicole L Stout Gergich; Lucinda A Pfalzer; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe Journal: Cancer Date: 2008-06-15 Impact factor: 6.860
Authors: Dale J Langford; Brian Schmidt; Jon D Levine; Gary Abrams; Charles Elboim; Laura Esserman; Deborah Hamolsky; Judy Mastick; Steven M Paul; Bruce Cooper; Kord Kober; Marylin Dodd; Laura Dunn; Bradley Aouizerat; Christine Miaskowski Journal: J Pain Symptom Manage Date: 2014-12-17 Impact factor: 3.612
Authors: Betty Smoot; Bruce A Cooper; Yvette Conley; Kord Kober; Jon D Levine; Judy Mastick; Kimberly Topp; Christine Miaskowski Journal: J Cancer Surviv Date: 2015-12-18 Impact factor: 4.442
Authors: Janet Chance-Hetzler; Jane Armer; Maggie Van Loo; Blake Anderson; Robin Harris; Rebecca Ewing; Bob Stewart Journal: J Pers Med Date: 2015-08-25
Authors: Helena Harder; Patrick Holroyd; Lynn Burkinshaw; Phil Watten; Charles Zammit; Peter R Harris; Anna Good; Val Jenkins Journal: J Cancer Surviv Date: 2017-07-24 Impact factor: 4.442
Authors: Elizabeth A Chrischilles; Danielle Riley; Elena Letuchy; Linda Koehler; Joan Neuner; Cheryl Jernigan; Brian Gryzlak; Neil Segal; Bradley McDowell; Brian Smith; Sonia L Sugg; Jane M Armer; Ingrid M Lizarraga Journal: Breast Cancer Res Treat Date: 2019-03-09 Impact factor: 4.872